Authors
Loading...
Qualitative study reveals significant financial and logistical challenges in accessing CAR T-cell therapy for patients with hematologic cancer.
Newell et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: